Method for determining cross contamination of mouse genes for human cells in a patient-derived xenograft cells
AssigneeAbion Inc.
InventorsYoon La Choi, Yun Su Lee
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbion Inc.
InventorsYoon La Choi, Yun Su Lee
Estimating the term…
The present application relates to a detection kit for genotypes capable of confirming cross contamination that may occur in a banking process of a patient-derived xenograft model or cell-derived xenograft model and a method for determining cross contamination using the same. According to the present disclosure, it is possible to determine all of cross contamination of mouse related genes, have high detection sensitivity and specificity to be close to 100%, rapidly examine the contamination, and be very useful in predicting mouse contamination. Therefore, according to the present disclosure, cross contamination of genes related with the human and the mouse is predicted in advance to be applied to evaluation of anticancer drug efficacy using a patient-derived xenograft model or cell-derived xenograft model and contribute to cell banks using the patient-derived xenograft model or cell-derived xenograft model, and as a result, the present disclosure is very useful in a medical industry.
A method for determining cross contamination of mouse genes for human cells in a method for determining patient-derived xenograft cells, the method comprising the steps of:
Dependencies are inferred from the claim text.